The Francis Crick Institute
Browse
1-s2.0-S187350612300096X-main.pdf (2.44 MB)

Establishment and characterization of an iPSC line (UCLi023-A) derived from a Late-Onset Retinal Degeneration patient carrying a founder mutation in C1QTNF5.

Download (2.44 MB)
journal contribution
posted on 2023-05-22, 10:09 authored by Ana Alonso-Carriazo Fernández, Phoebe Ashley-Norman, Zaynab Butt, Mariya Moosajee, Amanda-Jayne Francis Carr
Late-Onset Retinal Degeneration (L-ORD) is a rare autosomal dominant macular disease, with most cases being caused by a founder mutation in C1QTNF5. Initial symptoms, which generally occur during or after the sixth decade, include abnormal dark adaptation and changes in peripheral vision. Over time, the build-up of sub-retinal pigment epithelium (RPE) deposits leads to macular atrophy and bilateral central vision loss1. Here, we describe the generation of a human induced pluripotent stem cell (iPSC) line from dermal fibroblasts of a 61-year-old L-ORD Caucasian male patient carrying the founder mutation (c.489C>G, p.Ser163Arg), using episomal reprogramming.

History